Parcopa Interactions
There are 520 drugs known to interact with Parcopa (carbidopa/levodopa), along with 13 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 50 are major, 459 are moderate, and 11 are minor.
- View all 520 medications that may interact with Parcopa
- View Parcopa alcohol/food interactions (1)
- View Parcopa disease interactions (13)
Most frequently checked interactions
View interaction reports for Parcopa (carbidopa / levodopa) and the medicines listed below.
- amantadine
- amantadine
- aspirin
- aspirin
- Azilect (rasagiline)
- Azilect (rasagiline)
- Celebrex (celecoxib)
- Celebrex (celecoxib)
- clonazepam
- clonazepam
- Comtan (entacapone)
- Comtan (entacapone)
- Lexapro (escitalopram)
- Lexapro (escitalopram)
- lisinopril
- lisinopril
- MiraLAX (polyethylene glycol 3350)
- MiraLAX (polyethylene glycol 3350)
- Mirapex (pramipexole)
- Mirapex (pramipexole)
- Requip (ropinirole)
- Requip (ropinirole)
- tramadol
- tramadol
- Tylenol (acetaminophen)
- Tylenol (acetaminophen)
- Vitamin D3 (cholecalciferol)
- Vitamin D3 (cholecalciferol)
- Xanax (alprazolam)
- Xanax (alprazolam)
Parcopa alcohol/food interactions
There is 1 alcohol/food interaction with Parcopa (carbidopa / levodopa).
Parcopa disease interactions
There are 13 disease interactions with Parcopa (carbidopa / levodopa) which include:
- glaucoma
- cardiac disease
- neuroleptic malignant syndrome
- psychoses/depression
- glaucoma
- liver/renal
- melanoma
- reactive airway disease
- depression
- sleep disorders
- hypotension
- psychosis
- GI bleeding
Report options
More about Parcopa (carbidopa / levodopa)
- Parcopa consumer information
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: dopaminergic antiparkinsonism agents
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Sinemet
Sinemet is used to treat symptoms of Parkinson's disease, such as muscle stiffness, tremors ...
Cogentin
Cogentin is used for extrapyramidal reaction, parkinson's disease
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Rytary
Rytary is used to treat symptoms of Parkinson's disease and parkinsonism that may follow carbon ...
Exelon
Exelon (rivastigmine) is used to treat dementia caused by Alzheimer's or Parkinson's disease ...
Crexont
Crexont (carbidopa and levodopa) is an extended-release capsule that may be used to treat symptoms ...
Gocovri
Gocovri (amantadine) is used in the treatment of Parkinson's disease. Includes Gocovri side ...
Sinemet CR
Sinemet CR is used for GTP-CH Deficiency, neuroleptic malignant syndrome, parkinson's disease ...
Duopa
Duopa is used to treat movement problems in people with advanced Parkinson's disease. Learn about ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
